Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

What new medicines are poised to take the leap from breakthrough to approval in 2025? Here’s what to expect this year.

As the new year begins, individuals looking to improve their health might consider participating in clinical trials, ...

Dr. Robert A. Winn discusses efforts to increase diversity in clinical trials on an episode of Radio Health Journal.

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligence ...

Clinical trials in 2025 will be beset by rising costs and uncertain regulations while also benefiting from new technologies ...

After two recent deaths in gene therapy clinical trials, the industry needs to be more open to sharing information to protect ...

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, ...

Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a ...

In a conversation with The Regulatory Review, Ropes & Gray partner David Peloquin discusses how clinical research studies are ...

Alzheimer’s Disease, with exciting new therapeutic breakthroughs and advancements in clinical research that have redefined ...

Expands capabilities to accelerate clinical trials by adding advanced solutions including eCOA, eConsent, Visit Management, ...